Home › Funds › Eversept Partners, LP › BBNX

Eversept Partners, LP position in BBNX

BETA BIONICS INC · Health Care

Eversept Partners, LP reported holding 1,249,441 shares of BBNX (BETA BIONICS INC) in its Q2 2026 13F filing — a position valued at US$19.6M, representing 1.02% of its reported portfolio and ranking #28 among its reported holdings. Eversept Partners, LP has disclosed BBNX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.25M sh
Reported value held$19.58M
Portfolio Weight1.02%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Eversept Partners, LP's BBNX position evolved

Eversept Partners, LP first disclosed a stake in BBNX in Q4 2025 at 678,262 shares (US$20.7M). Across 3 filings, Eversept Partners, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,249,441 shares valued at US$19.6M — a reduction of -165,397 shares quarter over quarter.. Notable position changes include a 109% increase in Q1 2026 (shares rose 56% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 678.26K $20.67M New
Q1 2026 1.41M $14.18M Add
Q2 2026 1.25M $19.58M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BBNX and 13F data

BBNX (BETA BIONICS INC) is a Health Care company. 52 other funds we track also report a position in BBNX — the largest reported positions include EVENTIDE ASSET MANAGEMENT, LLC (US$98.1M), Soleus Capital Management, L.P. (US$68.8M), Sands Capital Alternatives, LLC (US$58.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BBNX

All BBNX fund holders →

FAQ

How long has Eversept Partners, LP held BBNX?

Eversept Partners, LP has disclosed BBNX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Eversept Partners, LP's current position in BBNX?

As of Q2 2026, Eversept Partners, LP holds 1.25M shares of BBNX (BETA BIONICS INC), valued at $19.58M, representing 1.02% of its reported portfolio and ranking #28.

Has Eversept Partners, LP been buying or selling BBNX?

In the latest 13F filing (Q2 2026), Eversept Partners, LP reduced its position in BBNX.

Which other funds hold BBNX?

Other major institutional holders of BBNX include EVENTIDE ASSET MANAGEMENT, LLC, Soleus Capital Management, L.P., Sands Capital Alternatives, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.